Financial PerformanceCash flows from operations in the quarter were $160.4 million, a very strong result versus the $61.0 million reported in the comparable quarter a year ago.
Market Position And ExpansionOption Care Health's broad portfolio of acute and chronic medications, offered through its national footprint of 182 locations, is seen as a key differentiator and meaningful competitive advantage.
Strategic OpportunitiesCoram's exit from acute therapies is expected to provide share gain opportunities for OPCH.